![Joanna Horobin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joanna Horobin
Directeur/Membre du Conseil chez
LIQUIDIA CORPORATION
Fortune : 950 108 $ au 31/05/2026
Profil
Joanna C.
Horobin currently works at Liquidia Technologies, Inc., as Independent Director from 2019, Liquidia Corp., as Independent Director from 2020, and Royal College of General Practitioners, as Member.
Dr. Horobin also formerly worked at iOnctura SA, as Non-Executive Chairman, The University of Manchester, as Director, Syndax Pharmaceuticals, Inc., as President & Director in 2012, Nascent Pharmaceuticals, Inc., as Director, Vyant Bio, Inc., as Independent Director from 2021 to 2023, Nordic Nanovector ASA, as Independent Non-Executive Director from 2016 to 2023, Kymera Therapeutics, Inc., as Independent Director from 2018 to 2024, CASI Pharmaceuticals, Inc., as Executive Vice President, Idera Pharmaceuticals, Inc., as Chief Medical Officer & Senior Vice President from 2015 to 2019, CombinatoRx, Inc., as Chief Operating Officer, Rhone-Poulenc Rorer, Inc., as Vice President-Oncology, and Verastem, Inc., as Chief Medical Officer from 2012 to 2015.
Dr. Horobin received her doctorate degree from The University of Manchester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,02% | 23/05/2026 | 15 359 ( 0,02% ) | 950 108 $ | 31/05/2026 |
Postes actifs de Joanna Horobin
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur/Membre du Conseil | 28/06/2020 |
Royal College of General Practitioners
 Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Directeur/Membre du Conseil | 11/09/2019 |
Anciens postes connus de Joanna Horobin
| Sociétés | Poste | Fin |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/06/2024 |
| VYANT BIO, INC. | Directeur/Membre du Conseil | 01/12/2023 |
| THOR MEDICAL | Directeur/Membre du Conseil | 03/01/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur Technique/Scientifique/R&D | 01/07/2019 |
| VERASTEM, INC. | Directeur Technique/Scientifique/R&D | 01/07/2015 |
Formation de Joanna Horobin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Nascent Pharmaceuticals, Inc.
 Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals & drugs | Health Technology |
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Vyant Bio, Inc.
 Vyant Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
